Naguib D, Bakchoul T, Dietrich S, Geisler T, Hackstein H, Kille A, Koschmieder S, Lehmann LH, Linke A, Petzold T, Pfister R, Olivier CB, Rühl H, Tiede A, Trautmann-Grill K, Hochholzer W, Polzin A (2025)
Publication Type: Journal article
Publication year: 2025
DOI: 10.1007/s12181-025-00767-3
Antithrombotic treatment is the backbone to prevent ischemic events in interventional cardiology; however, antithrombotic medication enhances the risk of bleeding. Oncological diseases are frequently associated with thrombocytopenia. The optimal antithrombotic regimen if these patients undergo interventional procedures is unknown. Hence, this consensus statement aims to provide a clinical guide to antithrombotic treatment options in these patients. As there are no sufficient data these recommendations are based on expert opinions.
APA:
Naguib, D., Bakchoul, T., Dietrich, S., Geisler, T., Hackstein, H., Kille, A.,... Polzin, A. (2025). Antithrombotische Therapie für kardiologische Eingriffe bei Patienten mit Thrombozytopenie bei onkologischen Erkrankungen. Die Kardiologie. https://doi.org/10.1007/s12181-025-00767-3
MLA:
Naguib, David, et al. "Antithrombotische Therapie für kardiologische Eingriffe bei Patienten mit Thrombozytopenie bei onkologischen Erkrankungen." Die Kardiologie (2025).
BibTeX: Download